- Home
- WST vs LI Comparison
WST vs LI Comparison
Compare WST & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- LI
- Stock Information
- Founded
- WST 1923
- LI 2015
- Country
- WST United States
- LI China
- Employees
- WST N/A
- LI N/A
- Industry
- WST Medical/Dental Instruments
- LI Auto Manufacturing
- Sector
- WST Health Care
- LI Consumer Discretionary
- Exchange
- WST Nasdaq
- LI Nasdaq
- Market Cap
- WST 23.2B
- LI 28.7B
- IPO Year
- WST N/A
- LI 2020
- Fundamental
- Price
- WST $322.46
- LI $22.32
- Analyst Decision
- WST Buy
- LI Buy
- Analyst Count
- WST 3
- LI 6
- Target Price
- WST $460.33
- LI $36.43
- AVG Volume (30 Days)
- WST 519.5K
- LI 5.5M
- Earning Date
- WST 10-24-2024
- LI 10-31-2024
- Dividend Yield
- WST 0.26%
- LI N/A
- EPS Growth
- WST N/A
- LI 56.67
- EPS
- WST 6.74
- LI 1.37
- Revenue
- WST $2,876,400,000.00
- LI $20,232,143,532.00
- Revenue This Year
- WST N/A
- LI $19.64
- Revenue Next Year
- WST $6.22
- LI $31.36
- P/E Ratio
- WST $47.85
- LI $16.34
- Revenue Growth
- WST N/A
- LI 42.25
- 52 Week Low
- WST $265.00
- LI $17.44
- 52 Week High
- WST $413.70
- LI $46.44
- Technical
- Relative Strength Index (RSI)
- WST 53.52
- LI 42.46
- Support Level
- WST $313.92
- LI $22.27
- Resistance Level
- WST $326.58
- LI $22.86
- Average True Range (ATR)
- WST 7.66
- LI 0.60
- MACD
- WST -0.61
- LI 0.05
- Stochastic Oscillator
- WST 84.86
- LI 22.48
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 376,000 NEVs in 2023, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.